Friday 6 November 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
282.32
4.14
−1.45%
Follow THC
Alert me
Tenet Healthcare Corporation (THC) SEC filings, changes and red flags
Red flags
-
Officer departure
Tenet Healthcare Corporation reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 13 added · 25 removed · 66 modified P2I1A: no material changes, the filing says |
||
| 8-K | Oct 29, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Sep 22, 2026 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | Sep 8, 2026 | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2026 |
P1I2: 16 added · 3 removed · 44 modified P2I1A: no material changes, the filing says |
||
| 8-K | Jul 23, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 27, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 10-Q | Mar 31, 2026 | |||
| 8-K | Apr 30, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 9, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | Officer departure | |
| 8-K | Mar 25, 2026 | 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2025 |
1: 14 added · 10 removed · 57 modified 1A: 4 added · 4 removed · 52 modified 7: 28 added · 58 removed · 121 modified |
||
| 8-K | Feb 11, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 27, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 21, 2025 | 5.02 Departure or appointment of directors or officers | ||
| 8-K | Nov 18, 2025 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 4, 2025 | 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 3, 2025 | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 | |||
| 8-K | Oct 28, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 | |||
| 8-K | Jul 22, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 | |||
| 8-K | Apr 29, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 | |||
| 8-K | Feb 12, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Oct 29, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 24, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 30, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 8, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 1, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits |